Pharmakotherapie der Insomnie im höheren Lebensalter

Schlaflosigkeit und nicht erholsamer Schlaf gehören zu den häufigen Beschwerden alter Menschen (1). Schätzungen gehen davon aus, dass etwa 30 bis 60 % der über 65-Jährigen von Schlafstörungen betroffen sind (2–4) und etwa 10 bis 40 % der älteren Menschen klagen über Schlaflosigkeit (Insomnie) (5, 6).

• Literatur

• 1 Park YM. et al. Changes of sleep or waking habits by age and sex in Japanese. Percept Mot Skills 2002; 94: 1199-1213.
• 2 Schubert CR, Cruickshanks KJ, Dalton DS. et al. Prevalence of sleep problems and quality of life in an older population. Sleep 2002; 25 (08) 889-893.
• 3 Foley D. et al. Sleep disturbances and chronic disease in older adults. J Psychosom Res 2004; 56 (05) 497-502.
• 4 Foley DJ. et al. Frequent napping is associated with excessive daytime sleepiness, depression, pain, and nocturia in older adults: findings from the NSF ’2003 Sleep in America’ Poll. Am J Geriatr Psych 2007; 15: 344-350.
• 5 Ohayon M. Epidemiological study on insomnia in the general population. Sleep 1996; 19 (Suppl. 03) S7-15.
• 6 Ohayon MM. Epidemiology of insomnia. Sleep Med Rev 2002; 6 (02) 97-111.
• 7 Ford DE, Kamerow DB. Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention?. JAMA 1989; 262 (11) 1479-1484.
• 8 Morgan K, Clarke D. Longitudinal trends in late-life insomnia: implications for prescribing. Age Ageing 1997; 26 (03) 179-184.
• 9 Morgan K. Daytime activity and risk factors for late-life insomnia. J Sleep Res 2003; 12 (03) 231-238.
• 10 Ohayon MM. et al. How age and daytime activities are related to insomnia in the general population: consequences for older people. J Am Geriatr Soc 2001; 49 (04) 360-366.
• 11 Morgan K. Sleep and aging. In: Lichstein KL, Morin CM. eds. Treatment of late-Life Insomnia. Thousand Oaks, CA: Sage; 2000
• 12 Morgan K, Clarke D. Risk factors for late-life insomnia in a representative general practice sample. Br J Gen Pract 1997; 47 (416) 166-169.
• 13 Jaussent A. I. et al. Hypnotics and mortality in an elderly general population. BMC Med 2013; 11: 212.
• 14 Schutte-Rodin S, Broch L, Buysse D. et al. Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med 2008; 4 (05) 487-504.
• 15 Krystal AD. The treatment of primary insomnia. CNS Spectr 2009; 14 (12) (Suppl. 13) 6-10.
• 16 Ohayon MM, Caulet M. Psychotropic medication and insomnia complaints in two epidemiological studies. Can J Psychiatry 1996; 41 (07) 457-464.
• 17 Hoffmann F, Schiemann G, Windt R. Privat oder Kasse? Einstellungen von Hausärzten und Apothekern zur Verordnung von Hypnotika. DMW 2014; 139 (22) 1153-1158.
• 18 Hoffmann F, Glaeske G, Scharffetter W. Zunehmender Hypnotikagebrauch auf Privatrezepten in Deutschland. Sucht 2006; 52: 360-366.
• 19 Morgan K. Sedative-hypnotic drug use and ageing. Arch Gerontol Geriatr 1983; 2 (03) 181-199.
• 20 Morgan K. Hypnotics in the elderly. What cause for concern? Drugs 1990; 40 (05) 688-696.
• 21 Morin CM. et al. Correlates of benzodiazepine use in individuals with insomnia. Sleep Med 2004; 5: 457-462.
• 22 Glass J, Lanctôt KL, Herrmann N. et al. Sedative hypnotics in older people with insomnia. BMJ 2005; 331 (7526) 1169.
• 23 Morin CM, Bastien CH, Brink D, Brown TR. Adverse effects of temazepam in older adults with chronic insomnia. Hum Psychopharmacol 2003; 18 (01) 75-82.
• 24 Roehrs T, Roth T. Insomnia pharmacotherapy. Neurotherapeutics 2012; 9 (04) 728-738.
• 25 Riedel BW, Lichstein KL. Insomnia and daytime functioning. Sleep Med Rev 2000; 4 (03) 277-298.
• 26 Avidan AY, Fries BE, James ML. et al. Insomnia and hypnotic use, recorded in the minimum data set, as predictors of falls and hip fractures in Michigan nursing homes. J Am Geriatr Soc 2005; 53 (06) 955-962.
• 27 Sivertsen B, Nordhus IH, Bjorvatn B, Pallesen S. Sleep problems in general practice: a national survey of assessment and treatment routines of general practitioners in Norway. J Sleep Res 2010; 19 (01) (Suppl. 01) 36-41.
• 28 Möhler H, Fritschy JM, Rudolph U. A new benzodiazepine pharmacology. J Pharmacol Exp Ther 2002; 300 (01) 2-8.
• 29 Hofmann W. Benzodiazepine in der Geriatrie. Z Gerontol Geriatr 2013; 46 (08) 769-776 quiz 776.
• 30 Nutt D. GABAA receptors: subtypes, regional distribution, and function. J Clin Sleep Med 2006; 2 (02) S7-11.
• 31 Nowell PD, Mazumdar S, Buysse DJ. et al. Benzodiazepines and zolpidem for chronic insomnia: a meta-analysis of treatment efficacy. JAMA 1997; 278 (24) 2170-2177.
• 32 Lader MH: Limitations on the use of benzodiazepines in anxiety and insomnia: are they justified?. Eur Neuropsychopharmacol 1999; 9 (Suppl. 06) S399-405
• 33 Lader M. Benzodiazepines revisited – will we ever learn?. Addiction 2011; 106 (12) 2086-2109
• 34 Cook PJ. Benzodiazepine hypnotics in the elderly. Acta Psychiatr Scand Suppl 1986; 332: 149-58.
• 35 Hausken AM, Furu K, Skurtveit S. et al. Starting insomnia treatment. Eur J Clin Pharmacol 2009; 65 (03) 295-301.
• 36 Allen RP. et al. Efficacy without tolerance or rebound insomnia for midazolam and temazepam after use for one to three months. J Clin Pharmacol 1987; 27 (10) 768-775.
• 37 Oswald I. et al. Benzodiazepine hypnotics remain effective for 24 weeks. Br Med J 1982; 284: 860-863.
• 38 Berry RB, Kouchi K, Bower J. et al. Triazolam in patients with obstructive sleep apnea. Am J Respir Crit Care Med 1995; 151: 450-454.
• 39 Ancoli-Israel S. Epidemiology of sleep disorders. Clin Geriatr Med 1989; 5 (02) 347-362.
• 40 Mysliwiec V. et al. Comorbid insomnia and obstructive sleep apnea in military personnel: correlation with polysomnographic variables. Mil Med 2014; 179 (03) 294-300.
• 41 Zhang XJ, Li QY, Wang Y. et al. The effect of non-benzodiazepine hypnotics on sleep quality and severity in patients with OSA. Sleep Breath. 2014
• 42 Kuhn-Thiel AM, Weiß C, Wehling M. Consensus validation of the FORTA (Fit fOR The Aged) List. Drugs Aging 2014; 31 (02) 131-140.
• 43 Schubert I, Küpper-Nybelen J, Ihle P, Thürmann P. Prescribing potentially inappropriate medication (PIM) in Germany’s elderly as indicated by the PRISCUS list. Pharmacoepidemiol Drug Saf 2013; 22 (07) 719-727.
• 44 Price SD, Holman CDJ, Sanfilippo FM, Emery JD. Association between potentially inappropriate medications from the Beers criteria and the risk of unplanned hospitalization in elderly patients. Ann Pharmacother 2014; 48 (01) 6-16.
• 45 Corsonello A. et al. Medications affecting functional status in older persons. Curr Pharm Des 2014; 20: 3256-3263.
• 46 Ungar A. et al. Fall prevention in the elderly. Clin Cases Miner Bone Metab 2013; 10 (02) 91-95.
• 47 Blake S. Preventing falls. Nurs N Z 2013; 19 (10) 29.
• 48 Ensrud KE, Blackwell T, Mangione CM. et al. Central nervous system active medications and risk for fractures in older women. Arch Intern Med 2003; 163 (08) 949-957.
• 49 Woolcott JC, Richardson KJ, Wiens MO. et al. Meta-analysis of the impact of 9 medication classes on falls in elderly persons. Arch Intern Med 2009; 169 (21) 1952-1960.
• 50 Modreker MK, Renteln-Kruse W von. Arzneimittel und Stürze im Alter. Internist (Berl) 2009; 50 (04) 493-500.
• 51 Bakken MS. et al. Risk of hip fracture among older people using anxiolytic and hypnotic drugs: a nationwide prospective cohort study. Eur J Clin Pharmacol. 2014
• 52 Vries OJ de. et al. The elimination half-life of benzodiazepines and fall risk. Age Ageing 2013; 42 (06) 764-770.
• 53 Ballokova A. et al. Use of benzodiazepines and association with falls in older people admitted to hospital: a prospective cohort study. Drugs Aging 2014; 31 (04) 299-310.
• 54 Finkle WD, Der JS, Greenland S. et al. Risk of fractures requiring hospitalization after an initial prescription for zolpidem, alprazolam, lorazepam, or diazepam in older adults. J Am Geriatr Soc 2011; 59 (10) 1883-1890.
• 55 Kolla BP. et al. Zolpidem is independently associated with increased risk of inpatient falls. J Hosp Med 2013; 8: 1-6.
• 56 Lai Y, Yang Y, Tsai M, Huang C, Chiou J. Benzodiazepine & nonbenzodiazepine prescriptions for Taiwanese elderly with type 2 diabetes contributes to cognitive dysfunction. Int Psychogeriatr 2014; 1-9.
• 57 Mura T. et al. Chronic use of benzodiazepines and latent cognitive decline in the elderly: results from the Three-city study. Eur Neuropsychopharmacol 2013; 23 (03) 212-223.
• 58 Schäfer U, Rüther E. Psychopharmakotherapie. Göttingen: Vandenhoeck & Ruprecht; 2006
• 59 Jenck F. et al. Evidence for a role of 5-HT1C receptors in the antiserotonergic properties of some antidepressant drugs. Eur J Pharmacol 1993; 231 (02) 223-229.
• 60 Richelson E. Pharmacology of antidepressants - characteristics of the ideal drug. Mayo Clin Proc 1994; 69 (11) 1069-1081.
• 61 Reinbold H, Assion H. Antidepressiva: Pharmakologische und klinische Aspekte. 2nd ed.. Dortmund: PGV PsychoGen-Verl; 2009
• 62 Hajak G. et al. Doxepin in the treatment of primary insomnia: a placebo-controlled, double-blind, polysomnographic study. J Clin Psychiatry 2001; 62 (06) 453-463.
• 63 Riemann D. et al. Trimipramine in primary insomnia: results of a polysomnographic double-blind controlled study. Pharmacopsychiatry 2002; 35 (05) 165-174.
• 64 Krystal AD. A compendium of placebo-controlled trials of the risks/benefits of pharmacological treatments for insomnia: the empirical basis for U.S. clinical practice. Sleep Med Rev 2009; 13 (04) 265-274.
• 65 Asplund. Sleep and hypnotic use in relation to perceived somatic and mental health among the elderly. Arch Gerontol Geriatr 2000; 31 (03) 199-205.
• 66 Cumbler E, Guerrasio J, Kim J, Glasheen J. Use of medications for insomnia in the hospitalized geriatric population. J Am Geriatr Soc 2008; 56 (03) 579-581.
• 67 Quach L, Yang FM, Berry SD. et al. Depression, antidepressants, and falls among community-dwelling elderly people: the MOBILIZE Boston study. J Gerontol A Biol Sci Med Sci 2013; 68 (12) 1575-1581.
• 68 Berry SD, Zhang Y, Lipsitz LA. et al. Antidepressant prescriptions: an acute window for falls in the nursing home. J Gerontol A Biol Sci Med Sci 2011; 66 (10) 1124-1130.
• 69 Giron MST. et al. Sleep problems in a very old population. J Gerontol A 2002; 57 (04) M236-40.
• 70 Roberts RE. et al. Sleep complaints and depression in an aging cohort. Am J Psychiatry 2000; 157: 81-88.
• 71 Bloom HG. et al. Evidence-based recommendations for the assessment and management of sleep disorders in older persons. J Am Geriatr Soc 2009; 57 (05) 761-789.
• 72 NIH State of the Science Conference statement on Manifestations and Management of Chronic Insomnia in Adults, June 13–15, 2005. Sleep 2005; 28 (09) 1049-1057.